Transcera
UEI: PG4ZWW1DSX69
• CAGE: 8HNJ5
Overview
Awardee Type
Parent
Company Description
Transcera is a founder-led, venture-backed biotech company formed in 2021 to translate discoveries from the Lencer and Chinnapen labs
Name
Transcera
Website
Headquarters
Cambridge, MA
United States
United States
Most Recent Award
June 1, 2023
Calculating
Federal grant recipient
TRANSCERA INC
(UEI PG4ZWW1DSX69, CAGE 8HNJ5)
is headquartered in Cambridge MA.
Its primary registered NAICS is 541714 Research and Development in Biotechnology (except Nanobiotechnology).
The corporation
was founded in August 2020 and
federally registered in
March 2020.
Federal Award Analysis
Transcera federal award history
$-
Contracts
$-
Subcontracts
$-
Grants
$-
Subgrants
$-
Total
No Results
Calculating
Calculating
No Results
Calculating
Calculating
No Results
Calculating
Calculating
| Year | Contracts | Subcontracts | Grants | Subgrants |
|---|
No Results
Calculating
Calculating
No Results
Calculating
Calculating
Federal Registration and Certifications
Legal Name
TRANSCERA INC
UEI
PG4ZWW1DSX69
CAGE Code
8HNJ5
SBA Certifications
None
Self Certifications
None
Entity Structure
Corporate Entity (Not Tax Exempt)
Purpose of Registration
Federal Contracts and Assistance
Date Founded
Aug. 21, 2020
Initial Registration
March 3, 2020
Last Registration
Jan. 21, 2025
Registration Activation
Jan. 24, 2024
Registration Expiration
Jan. 21, 2025
Fiscal Year End
December 31
Reported Entity Types
For Profit Organization
State of Incorporation
DE
Country of Incorporation
USA
Employees
<500
Accepts Credit Cards
No